The Rest Is Money cover image

213. The Decline And Fall Of The London Stock Exchange

The Rest Is Money

00:00

AstraZeneca's US Listing and Stamp Duty Risk

Robert explains AstraZeneca's US listing move, the UK depository receipt change, and its potential £200m stamp duty cost.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app